317 related articles for article (PubMed ID: 20445835)
21. Bipolar obsessive-compulsive disorder and personality disorders.
Maina G; Albert U; Pessina E; Bogetto F
Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
[TBL] [Abstract][Full Text] [Related]
22. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
23. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Wang Y; Zheng Y; Du Y; Song DH; Shin YJ; Cho SC; Kim BN; Ahn DH; Marquez-Caraveo ME; Gao H; Williams DW; Levine LR
Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
[TBL] [Abstract][Full Text] [Related]
24. Severity of childhood attention-deficit hyperactivity disorder--a risk factor for personality disorders in adult life?
Matthies S; van Elst LT; Feige B; Fischer D; Scheel C; Krogmann E; Perlov E; Ebert D; Philipsen A
J Pers Disord; 2011 Feb; 25(1):101-14. PubMed ID: 21309626
[TBL] [Abstract][Full Text] [Related]
25. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
[TBL] [Abstract][Full Text] [Related]
26. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a new procedure for the diagnostic assessment of personality disorder: the Multidimensional Personality Disorder Rating Scale (MPDRS).
Johnson JG; First MB; Cohen P; Kasen S
J Pers Disord; 2008 Jun; 22(3):246-58. PubMed ID: 18540797
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
Spencer TJ; Adler LA; McGough JJ; Muniz R; Jiang H; Pestreich L;
Biol Psychiatry; 2007 Jun; 61(12):1380-7. PubMed ID: 17137560
[TBL] [Abstract][Full Text] [Related]
29. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study.
Surman CB; Adamson JJ; Petty C; Biederman J; Kenealy DC; Levine M; Mick E; Faraone SV
J Clin Psychiatry; 2009 Nov; 70(11):1523-9. PubMed ID: 19646365
[TBL] [Abstract][Full Text] [Related]
30. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
31. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
[TBL] [Abstract][Full Text] [Related]
32. Twelve month test-retest reliability of a Japanese version of the Structured Clinical Interview for DSM-IV Personality Disorders.
Osone A; Takahashi S
Psychiatry Clin Neurosci; 2003 Oct; 57(5):532-8. PubMed ID: 12950709
[TBL] [Abstract][Full Text] [Related]
33. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
Steele M; Weiss M; Swanson J; Wang J; Prinzo RS; Binder CE
Can J Clin Pharmacol; 2006; 13(1):e50-62. PubMed ID: 16456216
[TBL] [Abstract][Full Text] [Related]
34. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
[TBL] [Abstract][Full Text] [Related]
35. Personality disorders in patients with burning mouth syndrome.
Maina G; Albert U; Gandolfo S; Vitalucci A; Bogetto F
J Pers Disord; 2005 Feb; 19(1):84-93. PubMed ID: 15899722
[TBL] [Abstract][Full Text] [Related]
36. Attention deficit/hyperactivity disorder in adults.
Moss SB; Nair R; Vallarino A; Wang S
Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
[TBL] [Abstract][Full Text] [Related]
37. Relationships of neuroticism and extraversion with axis I and II comorbidity among patients with DSM-IV major depressive disorder.
Jylhä P; Melartin T; Isometsä E
J Affect Disord; 2009 Apr; 114(1-3):110-21. PubMed ID: 18687471
[TBL] [Abstract][Full Text] [Related]
38. [Personality disorders in a nonclinical sample of adolescents].
Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
[TBL] [Abstract][Full Text] [Related]
39. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
